MY135292A - Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors - Google Patents

Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Info

Publication number
MY135292A
MY135292A MYPI20034180A MYPI20034180A MY135292A MY 135292 A MY135292 A MY 135292A MY PI20034180 A MYPI20034180 A MY PI20034180A MY PI20034180 A MYPI20034180 A MY PI20034180A MY 135292 A MY135292 A MY 135292A
Authority
MY
Malaysia
Prior art keywords
piperidine derivatives
uptake inhibitors
monoamine neurotransmitter
novel piperidine
novel
Prior art date
Application number
MYPI20034180A
Inventor
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of MY135292A publication Critical patent/MY135292A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

THIS INVENTION RELATES TO NOVEL PIPERIDINE DERIVATIVES USEFUL AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS.IN OTHER ASPECTS, THE INVENTION RELATES TO THE USE OF THESE COMPOUNDS IN A METHOD FOR THERAPY AND TO PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS OF THE INVENTION.
MYPI20034180A 2002-11-01 2003-10-31 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors MY135292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200201689 2002-11-01
DKPA200300727 2003-05-13

Publications (1)

Publication Number Publication Date
MY135292A true MY135292A (en) 2008-03-31

Family

ID=35295048

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20034180A MY135292A (en) 2002-11-01 2003-10-31 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Country Status (7)

Country Link
KR (1) KR20050071647A (en)
AR (1) AR041879A1 (en)
MY (1) MY135292A (en)
NO (1) NO20052624L (en)
NZ (1) NZ538514A (en)
RU (1) RU2325378C2 (en)
TW (1) TW200504017A (en)

Also Published As

Publication number Publication date
TW200504017A (en) 2005-02-01
RU2005107417A (en) 2006-01-20
NO20052624L (en) 2005-05-31
AR041879A1 (en) 2005-06-01
KR20050071647A (en) 2005-07-07
RU2325378C2 (en) 2008-05-27
NZ538514A (en) 2007-09-28

Similar Documents

Publication Publication Date Title
PL1797088T3 (en) Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200604173A (en) Novel compounds
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
NO20060360L (en) New 8-azabicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter reuptake inhibitors
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
TW200514772A (en) Novel tetrahydropyridine derivatives
HK1100559A1 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
MX2009005916A (en) Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors.
TW200800980A (en) Novel compounds
MXPA05013758A (en) Pharmaceutical compositions including an antihistamine and a stimulant and use thereof.
TW200508195A (en) 3-aminopyrrolidines as inhibitors of monoamine uptake
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
MX2010001075A (en) N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors.
MXPA05008314A (en) 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors.
PL375163A1 (en) Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2006075004A3 (en) 3, 8 - substituted 8-aza-bicyclo[3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
MX2009006213A (en) Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors.
MX2007002384A (en) Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors.
TW200603803A (en) Novel compounds
MY135292A (en) Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
UA89638C2 (en) Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200716627A (en) Novel compounds
TW200507844A (en) 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts
TW200603808A (en) Novel compounds
HK1093721A1 (en) Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it